Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. - Wikidata - awgldk - TriplyDB

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

http://www.wikidata.org/entity/Q52039136

about

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2 Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.CCR5 controls immune and metabolic functions during Toxoplasma gondii infection Chemokines in the immunopathogenesis of hepatitis C infection Clinical significance of the CCR5delta32 allele in hepatitis C Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population.Host genetic determinants of spontaneous hepatitis C clearance.Role of host genetic factors in the outcome of hepatitis C virus infection.Clinical implications of chemokines in acute and chronic hepatitis C virus infection.Host genetic determinants in hepatitis C virus infection.The role of CCR5 in HCV infection Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.CCR5 antagonists: the answer to inflammatory disease?Hepatitis C virus-mediated modulation of cellular immunity.The role of chemokines in hepatitis C virus-mediated liver disease The possible role of CCR5Δ32 mutation in Crimean-Congo hemorrhagic fever infection.CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.Chemokine receptor 5 (CCR5) polymorphism in chronic hepatitis B patients treated with three different nucleos(t)ide analogues.Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China.CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection.

P2860

Q24563937-E71BB82C-8791-4E5C-A30F-52CC6779DA6D Q27477986-778F8E94-B337-43D2-8520-7132D6A25098 Q27478113-4967CD8E-00A2-4D43-AA4D-FED51D98EAD2 Q27490393-4A3327F0-11DA-4BBC-B90F-02E15A6EE9FA Q27491039-57C3EECE-793D-4BE1-9F6B-C1F925F0BE34 Q28534869-A85B169F-A9A0-4A8A-824A-C6B9160B6486 Q33867870-54E7ADB7-209E-46A7-B0F8-9085F9FD32EA Q33908877-74A7E5D8-8AAA-421E-AEBC-4F2972348DBE Q33912466-76E41638-6B00-4CEF-A173-7814A6D0E815 Q34041961-52C25B51-5F64-4F3C-A641-0DE6744FF7E4 Q34056271-49924588-157D-4E31-96A9-7D9D0A1D954D Q34142349-7747028C-1BC2-4702-8670-30D06F2202D3 Q34169244-A5639F2E-A543-4DDF-8EAD-7C2254FB97E4 Q34297774-7AE17B23-5EF1-486A-A2AC-9263DA4B716E Q35011376-DF3536AD-0E2A-483D-B00B-0CBC432385E1 Q35259735-7E828C38-646E-40D9-90A3-8E656BCAC562 Q35561908-3F6479D7-33E5-449E-8BD4-F9F0EFF67EE3 Q35753723-165A98AE-89B3-4CCF-B0B0-205688D5A942 Q35960061-2C0717FE-03C8-463E-8119-9BAEDD8CFB07 Q36503328-030D4ECB-A3D1-438D-8E1D-A229FBFCE1E8 Q37196855-78241921-837E-4242-8C43-1D88CA9A7B6A Q37689783-69A732EF-7805-4813-9A71-BAF19B0BFDDE Q38036576-11766C98-1E93-4338-817D-D32F118F5A92 Q38197441-998FB445-3C9F-4635-A03E-99D7EA909383 Q38678588-DFF8C257-07F2-4A0B-99A7-DE4ABC48B5EB Q42062154-343B59F6-03B8-4CA6-8BF1-2866F0612BA3 Q42199375-3A8BF964-EDDE-430C-8B02-C760CF0C91AE Q42539595-5175A5A2-B5FD-4E65-8F54-70AD0D093919 Q42984759-B1891903-5172-4E99-A3D5-AB57549AEB99 Q43023517-34A7B3F2-B111-400E-B6BB-C8F74F16535C Q43115233-95ED73BC-03AC-4A9B-8EF1-8580748B8F2E Q44394482-F48B27A8-5667-4DB8-AF8D-B0C6781E591C Q47565807-D3676786-5C50-4ECB-A266-31B583A4203F Q50548814-D8E68AB8-3ECC-4136-84A8-9668A969D4D9

P2860

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

http://www.wikidata.org/entity/Q52039136

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@en

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@nl

type

label

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@en

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@nl

prefLabel

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@en

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@nl

P1433

Q52039136-16161DEE-F9F7-4804-9F26-A130FD1685D2

P1476

Q52039136-113B0EEA-71C2-4D99-A82F-C4C7B8159AE7

P2093

Q52039136-069607C4-4145-4819-9D11-5D8988478EA8

Q52039136-20E43EE9-E76F-4B72-BCF0-3C89F4750879

Q52039136-8039F16F-B205-41A8-9F84-34BBBCBE4545

Q52039136-AE486E4C-7AD3-4214-96DC-1F841F65BCE3

Q52039136-DF8DB5A7-B039-4436-A06B-05B2B4E1BDF0

Q52039136-E4443A46-368F-4F8C-9D87-475C42A36A6F

Q52039136-F630BA84-160B-4D2F-AB19-207DFE8A7E99

Q52039136-FF2D7580-D813-4985-A49B-E804236E54D9

P304

Q52039136-2119C585-4557-4CB2-AAB8-D8DD2D8DAC31

P31

Q52039136-82F0CCD6-5733-483A-9969-6ABBFA417C12

P356

Q52039136-B8292166-0FFD-40FE-A6FB-1DDADD42BCDB

P407

Q52039136-FD9AE345-E98E-49BD-946A-583C7CA67C69

P433

Q52039136-66B52D29-FE29-43DA-9089-55FA63A5281D

P478

Q52039136-11808E76-174F-4F88-83C0-0276A3B5B405

P50

Q52039136-5124FCFC-ECB8-49AE-B6FC-8D84457F76B7

Q52039136-6982625B-064D-448E-8130-3EA402A72A6C

P577

Q52039136-6332C9A2-CD56-4FDD-8B84-FAF5314E73B2

P698

Q52039136-A337E682-F97A-4A29-8C8E-0BFFA5959656

P356

GAST.2002.33660

P1433

Gastroenterology

P1476

Frequency of the HIV-protectiv ...... e is increased in hepatitis C.

@en

P2093

Agathe Iwan

http://www.w3.org/2001/XMLSchema#string

Bernd Kupfer

http://www.w3.org/2001/XMLSchema#string

Bertfried Matz

http://www.w3.org/2001/XMLSchema#string

Hans H Brackmann

http://www.w3.org/2001/XMLSchema#string

Rainer P Woitas

http://www.w3.org/2001/XMLSchema#string

Ruth Offergeld

http://www.w3.org/2001/XMLSchema#string

Tilman Sauerbruch

http://www.w3.org/2001/XMLSchema#string

Ulrich Spengler

http://www.w3.org/2001/XMLSchema#string

P304

1721-1728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/GAST.2002.33660

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Jürgen Rockstroh

Golo Ahlenstiel

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12055576

http://www.w3.org/2001/XMLSchema#string